4-Week Reminder: Abstract Submission for #BOPA2026
Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN 4 Weeks left to submit your Abstract for the 29th Annual BOPA Conference 2026. Submit your work…
Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN 4 Weeks left to submit your Abstract for the 29th Annual BOPA Conference 2026. Submit your work…
📅 Friday 5 June 2026 🕐 12:00–16:00 📍 1 Frith Street, London W1D 3HZ ✅ Register here About this event NIHR INSIGHT South London welcomes you to join us for an afternoon dedicated…
Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN Delegates are invited to present results of their clinical and technical work as a poster with…
You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…
Abstract Submission for the 29th Annual BOPA Conference 2026 opens on 30th March 2026 Delegates are invited to present results of their clinical and technical work as a…
Dear BOPA member, The BOPA digital subcommittee is conducting a short survey to better understand how pharmacy healthcare professionals working in oncology use social media and how they prefer to…
We’re delighted to share that the BOPA abstracts presented at the 28th Annual BOPA Conference have now been published in the Journal of Oncology Pharmacy Practice. Huge congratulations to everyone…
We are inviting pharmacy professionals working in UK cancer services to take part in our study. What this research is about? To explore how pharmacy teams optimise medication for older…
The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026. BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…
The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…
The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…